Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

GE Vscan [1400×150]

GE Vscan [1400x150]

Enovacom SickKids case study

Enovacom SickKids case study

Diagnostics

MRI innovation makes cancerous tissue light up

March 23, 2022


Alex WongWATERLOO, Ont. – A new form of magnetic resonance imaging (MRI) that makes cancerous tissue glow in medical images could help doctors more accurately detect and track the progression of cancer over time. The innovation, developed by researchers at the University of Waterloo, creates images in which cancerous tissue appears to light up compared to healthy tissue, making it easier to see.

“Our studies show this new technology has promising potential to improve cancer screening, prognosis and treatment planning,” said Alexander Wong (pictured), Canada Research Chair in artificial intelligence and medical imaging and a professor of systems design engineering at Waterloo.

Irregular packing of cells leads to differences in the way water molecules move in cancerous tissue compared to healthy tissue. The new technology, called synthetic correlated diffusion imaging, highlights these differences by capturing, synthesizing and mixing MRI signals at different gradient pulse strengths and timings.

In the largest study of its kind, the researchers collaborated with medical experts at the Lunenfeld-Tanenbaum Research Institute, several Toronto hospitals and the Ontario Institute for Cancer Research to apply the technology to a cohort of 200 patients with prostate cancer.

Compared to standard MRI techniques, synthetic correlated diffusion imaging was better at delineating significant cancerous tissue, making it a potentially powerful tool for doctors and radiologists.

“Prostate cancer is the second most common cancer in men worldwide and the most frequently diagnosed cancer among men in more developed countries,” said Wong, also a director of the Vision and Image Processing (VIP) Lab at Waterloo. “That’s why we targeted it first in our research.

“We also have very promising results for breast cancer screening, detection, and treatment planning. This could be a game-changer for many kinds of cancer imaging and clinical decision support.”

The core research team also included Hayden Gunraj and Vignesh Sivan, engineering graduate students at Waterloo, and Dr. Masoom Haider of the Lunenfeld-Tanenbaum Research Institute.

Their paper, Synthetic correlated diffusion imaging hyperintensity delineates clinically significant prostate cancer, appears in the journal Scientific Reports.

PreviousNext

VG2022

VG2022

News and Trends

  • COVID-19 had a big impact on data management
  • GE to accelerate commercialization of AI innovations
  • Unique homecare EMR designed by clinicians for clinicians
  • London hospitals offer virtual-visits designed for inclusiveness
  • How technology can be deployed to assist the aged and their families
More from the Print Edition

Subscribe

Subscribe

Free of charge to Canadian hospital managers and executives in nursing homes and home-care organizations. Learn More

Follow us on Social Media!

Follow us on Social Media!

Infoway [May2022]

Infoway [May2022]

eHealth 2022

eHealth 2022

MEDICA 2022

MEDICA 2022

Advertise with us

Advertise with us

Calian-Fraser Health

Calian-Fraser Health

Sectra best in KLAS

Sectra best in KLAS

Zebra [May2022]

Zebra [May2022]

Cdn Institute HCI West

Cdn Institute HCI West

Talkdesk

Talkdesk

VG2022

VG2022

VG2022

VG2022

Advertise with us

Advertise with us

Calian-Fraser Health

Calian-Fraser Health

Sectra best in KLAS

Sectra best in KLAS

Zebra [May2022]

Zebra [May2022]

Cdn Institute HCI West

Cdn Institute HCI West

Talkdesk

Talkdesk

VG2022

VG2022

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 207
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2022 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us